Breath Gas Measurement of Propofol During Anesthesia in Patients With

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Propofol can be measured continuously in breath gas during anesthesia. This study compares propofol concentration in plasma and breath gas and processed electroencephalographic monitoring (bispectral index) under clinical conditions with patients and total intravenous anesthesia. Target controlled infusion technique is used to deliver adequate propofol concentration in plasma.

See also
Status	Clinical Trial	Phase
Completed	`NCT04498208` - Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery	N/A
Completed	`NCT03022136` - To Map Human Lower Thoracic Dermatomes by Epidural Block	N/A
Recruiting	`NCT04152720` - Evaluate the Efficacy and Safety of Prevention of Infection Foley Catheter as Compared to Conventional Foley Catheter	N/A

NCT number	NCT01835340
Study type	Interventional
Source	University of Luebeck
Contact
Status	Completed
Phase	N/A
Start date	October 2012
Completion date	December 9, 2017

Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms